Allurion Technologies develops a swallowable gastric balloon for weight loss.
Allurion Technologies has developed a swallowable gastric balloon for weight loss that does not require surgery, endoscopy, or anesthesia. The company's balloon, in contrast to other FDA-approved balloons that need sedation and endoscopy for placement or removal, could change the weight loss landscape in the near future. Allurion is leading a clinical trial to support its balloon's FDA approval. The company anticipates the results by the end of 2024 and plans to submit its application to the FDA afterward.
January 29, 2024
6 Articles